JP2022536653A5 - - Google Patents

Info

Publication number
JP2022536653A5
JP2022536653A5 JP2021573215A JP2021573215A JP2022536653A5 JP 2022536653 A5 JP2022536653 A5 JP 2022536653A5 JP 2021573215 A JP2021573215 A JP 2021573215A JP 2021573215 A JP2021573215 A JP 2021573215A JP 2022536653 A5 JP2022536653 A5 JP 2022536653A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
akg
composition according
sasp
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021573215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536653A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/036974 external-priority patent/WO2020252005A1/en
Publication of JP2022536653A publication Critical patent/JP2022536653A/ja
Publication of JP2022536653A5 publication Critical patent/JP2022536653A5/ja
Pending legal-status Critical Current

Links

JP2021573215A 2019-06-10 2020-06-10 老化関連分泌表現型を修整する方法および組成物 Pending JP2022536653A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962859623P 2019-06-10 2019-06-10
US62/859,623 2019-06-10
PCT/US2020/036974 WO2020252005A1 (en) 2019-06-10 2020-06-10 Methods and compositions for altering senescence associated secretory phenotype

Publications (2)

Publication Number Publication Date
JP2022536653A JP2022536653A (ja) 2022-08-18
JP2022536653A5 true JP2022536653A5 (cg-RX-API-DMAC7.html) 2023-06-16

Family

ID=73781254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573215A Pending JP2022536653A (ja) 2019-06-10 2020-06-10 老化関連分泌表現型を修整する方法および組成物

Country Status (7)

Country Link
US (1) US20220241229A1 (cg-RX-API-DMAC7.html)
EP (1) EP3980000A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022536653A (cg-RX-API-DMAC7.html)
CN (1) CN114126599A (cg-RX-API-DMAC7.html)
AU (1) AU2020293094A1 (cg-RX-API-DMAC7.html)
CA (1) CA3142781A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020252005A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112955139B (zh) 2018-09-25 2025-04-18 庞塞迪利昂健康特定活动公司 用于制备α-酮戊二酸钙的方法
DE102021111719A1 (de) * 2021-05-05 2022-11-10 Henkel Ag & Co. Kgaa Erhalt der Haarstruktur gegenüber Umwelteinflüssen umfassend ein Phenol und multivalente Ionen
WO2023191106A1 (ja) * 2022-04-01 2023-10-05 公益財団法人がん研究会 老化細胞もしくはsaspを標的とした治療薬/予防薬、老化細胞を検出するデータの取得方法及び治療薬/予防薬のスクリーニング方法
EP4561696A4 (en) * 2022-06-30 2026-07-15 Mechanobiologics Inc REVERSAL OF CELLULAR SENENCE BY LOW-FREQUENCY ULTRASOUND TREATMENT
CN115813784A (zh) * 2022-11-28 2023-03-21 麦吉丽生物科技有限公司 α-酮戊二酸、含有α-酮戊二酸的米发酵液在制备皮肤炎症抑制剂中的用途
WO2024123738A1 (en) * 2022-12-06 2024-06-13 Ponce De Leon Health Designated Activity Company Compositions and methods for treating diseases responsive to akg-vitamin b coadministration

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198465A (en) * 1991-06-19 1993-03-30 Dioguardi Francesco S Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
CA2447357A1 (en) * 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
ES2510690T3 (es) * 2004-12-17 2014-10-21 Alan B. Cash Método para extender la esperanza de vida y retrasar la aparición de enfermedad relacionada con la edad
US20070105942A1 (en) * 2005-11-08 2007-05-10 Heuer Marvin A Supplemental dietary composition for turning on anabolic switches in muscle, stimulating and/or optimizing protein synthesis, and/or potently signaling muscle building and/or growth via molecular pathways
PL379512A1 (pl) * 2006-04-21 2007-10-29 Sgp & Sons Ab Nowe metody i ich zastosowanie
US20110039935A1 (en) * 2007-07-02 2011-02-17 Entress Ab Use of pharmacologically active chemical compounds
DE102009016119A1 (de) * 2009-04-03 2010-10-14 Evonik Degussa Gmbh Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie
JP2014512372A (ja) * 2011-04-18 2014-05-22 ネステク ソシエテ アノニム α−HICA及びエイコサペンタエン酸を含有する栄養組成物
WO2014116985A1 (en) * 2013-01-25 2014-07-31 Winning The Fight Inc. Composition for treatment of neurodegenerative disease
US9993472B2 (en) * 2014-01-28 2018-06-12 Unity Biotechnology, Inc. Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2
CN113082009A (zh) * 2014-02-12 2021-07-09 加利福尼亚大学董事会 用于治疗衰老和与年龄相关的疾病和症状的组合物和方法
CN106963749A (zh) * 2017-03-23 2017-07-21 华南农业大学 α‑酮戊二酸(盐)在抗疲劳和提高肌肉运动力量方面的应用
CA3061381A1 (en) * 2017-04-25 2018-11-01 Buck Institute For Research On Aging COMPOSITIONS COMPRISING α-KETOGLUTARATE FOR EXTENDING LIFESPAN AND HEALTHSPAN
CN108774203A (zh) * 2018-06-25 2018-11-09 北京未蓝时代科技有限公司 一种延缓哺乳动物细胞和机体衰老的化合物及其应用
US20210369750A1 (en) * 2018-10-24 2021-12-02 Ponce De Leon Health Designated Activity Company Nicotinamide riboside compositions for healthspan extension

Similar Documents

Publication Publication Date Title
Tsujino et al. Pulmonary activation of vitamin D3 and preventive effect against interstitial pneumonia
JP7152552B2 (ja) 細胞外小胞による疾患の診断方法
Arakawa et al. Secretory immunoglobulin A induces human lung fibroblasts to produce inflammatory cytokines and undergo activation
US20230107216A1 (en) Pantetheine derivatives and uses thereof
AU2026202508A1 (en) Matrix bound vesicles (mbvs) containing il-33 and their use
US10006003B2 (en) Compositions and methods for flowable allograft amniotic tissue
Wu et al. Unfolded protein response factor ATF6 augments T helper cell responses and promotes mixed granulocytic airway inflammation
Goto et al. Hyperocclusion stimulates osteoclastogenesis via CCL2 expression
Takahashi et al. Porphyromonas gingivalis Mfa1 fimbria putatively binds to TLR2 and induces both IL-6 and IL-8 production in human bronchial epithelial cells
Fu et al. CD81+ senescent-like fibroblasts exaggerate inflammation and activate neutrophils via C3/C3aR1 axis in periodontitis
Wielińska et al. Interleukin 6 gene polymorphism is associated with protein serum level and disease activity in Polish patients with rheumatoid arthritis
Gibb et al. An in vitro alveolar model allows for the rapid assessment of chemical respiratory sensitization with modifiable biomarker endpoints
Martin et al. Whole blood transcriptomics reveals granulocyte colony‐stimulating factor as a mediator of cardiopulmonary bypass‐induced systemic inflammatory response syndrome
Tirelli et al. Effects of methylglyoxal on intestine and microbiome composition in aged mice
Yan et al. Mycoplasma ovipnuemoniae impairs the immune response of sheep and suppresses neutrophil function by inhibiting S100A9
WO2010086854A1 (en) Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
Rodriguez et al. Aging and chronic high-fat feeding negatively affect kidney size, function, and gene expression in CTRP1-deficient mice
JP2013525820A5 (cg-RX-API-DMAC7.html)
EP3947347A1 (en) Pantethenoylcysteine derivatives and uses thereof
US20180311199A1 (en) Combination treatment for inflammatory diseases
CN117285595B (zh) 一种具有肠屏障保护功能的五肽lk5及其应用
Kubo et al. p63 induces CD4+ T-cell chemoattractant TARC/CCL17 in human epithelial cells
JP2016088926A5 (cg-RX-API-DMAC7.html)
Rakhmatullina et al. Immune system of periodontium and identification of professional conditions in limestone quarry workers
CN121987626A (zh) 麦角硫因制剂在制备用于重塑炎症相关dna甲基化谱和/或降低表观遗传年龄的产品中的应用